Basic pharmacological properties of prenalterol

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Basic pharmacological properties of prenalterol

Abstract

References

A potent new beta2-adrenoceptor blocking agent

Analysis of the beta-receptor mediated effect on slow-contracting skeletal muscle in vitro

Differentiation of cardiac chronotropic and inotropic effects of beta-adrenoceptor agonists

Haemodynamic effects of a new beta 1-receptor agonist in acute myocardial infarction. A useful antidote to unwanted cardiac effects of beta-blocking agents

Cyclic AMP levels in ischaemic and non-ischaemic myocardium following coronary artery ligation: relation to ventricular fibrillation

On spare beta-adrenoceptors of inotropic effect of catecholamines in kitten ventricle

Correlation between the effects of salbutamol on contractions and cyclic AMP content of isolated fast-and slow-contracting muscles of the guinea pig

Differentiation of receptor systems activated by sympathomimetic amines

Prenalterol, a non-selective beta-adrenoceptor ligand with absolute beta1-selective partial agonist activity

beta 1-Adrenoceptors mediating relaxation of the guinea-pig trachea: experiments with prenalterol, a beta 1-selective adrenoceptor agonist

Citations

Effects of prenalterol and volume loading with dextran on haemodynamics and oxygen consumption in dogs during high epidural block with special reference to the splanchnic region

Effect of norepinephrine, prenalterol and metoprolol on the histochemical localization of adenylate cyclase activity in the brown adipose tissue of newborn rat

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Related Papers

Intravenous prenalterol in acute and chronic heart failure

In vitro studies on the cardiac activity of prenalterol with reference to use in congestive heart failure

Short and long-term effects of hydralazine and combined hydralazine and prenalterol therapy in patients with congestive heart failure

Prenalterol as an antidote to massive doses of metoprolol--a cardiovascular study in the dog

Long-term effect of a new beta-agonist prenalterol in patients with severe congestive heart failure (author's transl)